Can local intramuscular botulinum toxin improve dysphagia in patients with myopathic dysphagia and constriction of the cricoid muscle?

Trial Profile

Can local intramuscular botulinum toxin improve dysphagia in patients with myopathic dysphagia and constriction of the cricoid muscle?

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Deglutition disorders; Inclusion body myositis; Oculopharyngeal muscular dystrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top